MALVERN, Pa., Dec. 18, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT) , the leading remote medical technology company focused on the delivery of health information to improve quality of ...

The wide range of migratory behaviours across animal taxa has always fascinated the scientific community. Biotelemetry is a powerful tool that yields information about the underlying physiology. It ...

Philips announced this past week that it will acquire BioTelemetry, a provider of remote cardiac diagnostics and monitoring, for $2.8 billion. The transaction is expected to be completed in the first ...

Philips aims to broaden the reach of its digital patient monitoring platforms, from inside the hospital out to the home, through a $2.8 billion acquisition deal for BioTelemetry and its wearable heart ...

BioTelemetry BEAT recently announced the receipt of CE mark for its Holter analysis software. This approval is expected to exclusively strengthen the company’s foothold in the growing Holter ...

BioTelemetry gained as much as 18% on Friday after news that the cardiac-diagnostics company will be acquired by Dutch company Royal Philips for $2.8 billion. Shares of BioTelemetry rose from Thursday ...

Scaling down electronics isn't only important when building consumer devices, it also has a hufe impact on the world of implantable medical devices. However, as with all things technological, ...

Researchers are the first to characterize the ecology and fine-scale habitat use of 'near threatened' whitespotted eagle rays in Florida while also identifying areas of potential interactions between ...

BioTelemetry, a technology company focused on health information delivery, has acquired Telcare, a digital diabetes management platform. Telcare developed the first FDA-cleared cellular enabled blood ...

BioTelemetry (NASDAQ:BEAT) stock has suffered worse than most from the effects of the coronavirus pandemic, falling by 47% in March from a 1-year peak of $54 to $28.5, but the stock has recovered well ...